In the Boardroom
Refine Search
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Pharmaceutical
Robert Mulroy, the chief executive of USA-based Merrimack Pharmaceuticals has resigned after 17 years in the role as the company undergoes a major restructuring which will see its workforce cut by 22%. 4 October 2016
Pharmaceutical
UK pharma major GlaxoSmithKline today announced that Brian McNamara has been appointed chief executive of GSK’s Consumer Healthcare division effective immediately. 29 September 2016
Pharmaceutical
Denmark’s Bavarian Nordic has appointed Christopher Heery as chief medical officer of the company. 28 September 2016
Pharmaceutical
Germany’s Merck KGaA has appointed Isabel De Paoli as chief strategy officer effective October 1, 2016. 26 September 2016
Pharmaceutical
Family-owned Italian pharma company Zambon has appointed Roberto Tascione as its new chief executive to drive the business on a global scale. 20 September 2016
Pharmaceutical
GlaxoSmithKline’s decision to appoint Emma Walmsley as chief executive is a clear commitment to past strategy but an acknowledgement that a fresh, and arguably more commercially astute, approach is required to return the company to growth. 20 September 2016
Pharmaceutical
GlaxoSmithKline today announces that Emma Walmsley, currently chief executive of GSK’s Consumer Healthcare division, is appointed GSK CEO designate and will succeed Sir Andrew Witty as GSK CEO. 20 September 2016
Pharmaceutical
Egalet Corp has today announced the appointment of Patrick Shea as chief commercial officer (CCO). 19 September 2016
Pharmaceutical
Eli Lilly said today that Levi Garraway, a world leader in the analysis of cancer genomics and resistance to targeted therapies, will join Lilly as senior vice president, Global Development & Medical Affairs, for Lilly's Oncology business on January 1, 2017. 14 September 2016
Pharmaceutical
US pharma giant Pfizer said today that Dr Ole Isacson, a world-renowned scientist and thought leader in neurology, will become chief scientific officer of the Neuroscience Research unit and senior vice president, effective September 16. 7 September 2016
Pharmaceutical
Japanese drug major Daiichi Sankyo (TYO: 4568) today announced the appointment of Marielle Cohard-Radice, as executive vice president, global head of development, effective September 2, 2016. 6 September 2016
Pharmaceutical
The director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced his intention to stand down. 1 September 2016
Pharmaceutical
Danish diabetes giant Novo Nordisk has announced the retirement of its chief executive Lars Rebien Sørensen. 1 September 2016
Pharmaceutical
Experienced finance leader Paul Herendeen has been named executive vice president and chief financial officer (CFO) of Canadian drugmaker Valeant. 23 August 2016
Pharmaceutical
Following the death of Giovanni Recordati, who was chairman and chief executive of the largely family-owned Italian drugmaker Recordati, the company’s board of directors has decided to appoint Alberto Recordati, a brother of Giovanni, as chairman and Andrea Recordati as vice chairman and chief executive. 17 August 2016
Pharmaceutical
Italian drugmaker Recordati announced today that its chairman and chief executive, Giovanni Recordati, aged 66, has passed away following a long illness. 16 August 2016
Pharmaceutical
US pharma major Eli Lilly has announced that Joshua Smiley will be appointed to the post of senior vice president, finance, and treasurer effective October 1. 11 August 2016
Pharmaceutical
A series of changes to the executive management team have been announced by Canada-based Valeant Pharmaceuticals and its new chief executive Joe Papa. 9 August 2016
Pharmaceutical
US pharma major Eli Lilly is to have an new president and chief executive effective next year, as incumbent John Lechleiter is to retire at the end of 2016, the company has announced. 27 July 2016
Pharmaceutical
Fouad Namouni has been appointed oncology development head at US pharma major Bristol-Myers Squibb, effective July 25, 2016. 26 July 2016
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze